The Journal of thoracic and cardiovascular surgery · 2025
Spatial metrics of lymph node metastasis refine prognostic stratification of T1-T2 esophageal squamous cell carcinoma.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lin Chuanquan, Chen Maohui, Huang Yizhou, Zhang Shuliang, Chen Chun, Zheng Bin, Zheng Wei
Аннотация
OBJECTIVES: To determine whether the spatial extent of lymph node metastases (LNM) predicts survival in early esophageal squamous cell carcinoma (ESCC).
METHODS: A retrospective cohort of 185 patients with T1-T2 ESCC and pathologically confirmed LNM who underwent radical esophagectomy were enrolled in this study. We defined maximal LNM distance as the linear distance from the tumor to the farthest metastatic lymph node and cross-zonal dissemination (Δ) as the number of anatomical zonal boundaries between the tumor and the farthest node. Survival outcomes were assessed by Kaplan-Meier and multivariable Cox regression.
RESULTS: X-tile analysis identified 45 mm as the optimal cutoff for LNM distance, above which overall survival was significantly reduced (log-rank P < .001). On multivariable analysis, both N2 stage (hazard ratios [HR], 5.13; 95% confidence interval [CI], 1.47-17.91; P = .010) and LNM distance >45 mm (HR, 2.06; 95% CI, 1.07-3.96; P = .030) were independent predictors of mortality. Cross-zonal dissemination was observed in 51.9% of patients. Moreover, patients with Δ1+Δ2 involvement exhibited significantly worse overall and disease-free survival compared with those with Δ0 (overall survival P = .004; disease-free survival P = .034). Multivariable analysis confirmed Δ1+Δ2 as an independent prognostic factor (HR, 1.93; 95% CI, 1.01-3.67; P = .045).
CONCLUSIONS: In T1-T2 ESCC, both metastatic distance and cross-zonal dissemination provide independent prognostic information beyond simple lymph node counts. Therefore, incorporating spatial metrics into staging may improve risk stratification and guide treatment decisions.
METHODS: A retrospective cohort of 185 patients with T1-T2 ESCC and pathologically confirmed LNM who underwent radical esophagectomy were enrolled in this study. We defined maximal LNM distance as the linear distance from the tumor to the farthest metastatic lymph node and cross-zonal dissemination (Δ) as the number of anatomical zonal boundaries between the tumor and the farthest node. Survival outcomes were assessed by Kaplan-Meier and multivariable Cox regression.
RESULTS: X-tile analysis identified 45 mm as the optimal cutoff for LNM distance, above which overall survival was significantly reduced (log-rank P < .001). On multivariable analysis, both N2 stage (hazard ratios [HR], 5.13; 95% confidence interval [CI], 1.47-17.91; P = .010) and LNM distance >45 mm (HR, 2.06; 95% CI, 1.07-3.96; P = .030) were independent predictors of mortality. Cross-zonal dissemination was observed in 51.9% of patients. Moreover, patients with Δ1+Δ2 involvement exhibited significantly worse overall and disease-free survival compared with those with Δ0 (overall survival P = .004; disease-free survival P = .034). Multivariable analysis confirmed Δ1+Δ2 as an independent prognostic factor (HR, 1.93; 95% CI, 1.01-3.67; P = .045).
CONCLUSIONS: In T1-T2 ESCC, both metastatic distance and cross-zonal dissemination provide independent prognostic information beyond simple lymph node counts. Therefore, incorporating spatial metrics into staging may improve risk stratification and guide treatment decisions.